American Biotech Labs Announces Results of Preliminary Tests for Multiple Avian Bird Flu Strains Using Patented ABL SilverSol Technology(TM)
Tuesday October 9, 7:00 am ET
Clifton Mining Company Inc. (OTC : CFTN)
In separate in vitro tests against two strains of the H5N1 avian bird flu subtype, both instances of the virus were successfully neutralized by the American Biotech Labs' ABL SilverSol Technology products; the most recent findings are consistent with prior test using company products against the H3N2 and H1N1 flu subtypes.
SALT LAKE CITY, Oct. 9 /PRNewswire-FirstCall/ - American Biotech Labs (ABL; www.AmericanBiotechLabs.com), creator of a line of powerful products that utilize patented ABL SilverSol Technology(TM) to combat many of the world's most harmful pathogens, today announced successful preliminary results on tests performed using the company's products against three strains of the avian bird flu virus.
ADVERTISEMENT
Preliminary in vitro tests performed by two separate independent laboratories, using the company's ABL SilverSol Technology(TM) at 10 parts per million against two strains of the H5-N1 and H3-N2 subtype of the Avian Bird Flu virus, indicated that the ABL products could neutralize the virus.
"While we understand that these are preliminary studies, we are extremely encouraged by the results of this initial testing," said Keith Moeller, a managing director at American Biotech Labs. "Our intent with these studies is to test the ability of the product to disarm or kill the Avian flu virus in a laboratory setting. It is a necessary and valuable next step in our continued efforts to gain an understanding of what this technology can do."
The preliminary results of the tests using ABL products against the H5N1 avian bird flu virus are consistent with a variety of previous tests conducted using company products against the H3N2 and H1N1 flu subtypes. In all cases, ABL SilverSol Technology(TM) was able to successfully neutralize the virus.
ABL is engaged in continuing testing and study programs with a variety of groups and labs in the United States and other nations examining the potential applications of ABL SilverSol Technology(TM).
About American Biotech Labs
American Biotech Labs (ABL; www.AmericanBiotechLabs.com), founded in 1998, utilizes patented processes and technology to create singularly powerful and effective nano-catalytic silver products. In extensive testing performed by a variety of respected laboratories and researchers, ABL's nano-catalytic silver hydrosol has consistently demonstrated the ability to destroy a wide range of microbes - bacteria, viruses and molds. ABL products can be found at GNC and other fine health food stores under the Silver Biotics® label.
Clifton Mining Company owns approximately 23% of ABL. Clifton trades on the U.S. OTC: (CFTN). |
